Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07014059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous Serum Obtained by a Closed-Circuit Collection Device

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 10, 2025 (before its estimated June 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Autologous serum eye drops (ASED) are an established therapy for ocular surface diseases; however, their preparation can be costly and may not be available due to the need for germ-free conditions. This pilot trial assesses the feasibility of collecting ASED in a closed-circuit system for patients with chronic ocular surface diseases.
Trial Details
NCT Number NCT07014059
Lead Sponsor GIANCARLO FATOBENE
Collaborators: JP Farma
Conditions
(from sponsor)		 GVHD, Meibomian Gland Dysfunction (Disorder), Stevens-Johnson Syndrome, Limbal Keratoconjunctivitis, Recurrent Erosions of Persistent Epithelial Defects, Neurotrophic Ulcer, Sjogren Syndrome With Keratoconjunctivitis
Related terms Graft vs Host Disease, Meibomian Gland Dysfunction, Stevens-Johnson Syndrome
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov